You searched for "innovation"
Presenting the new Surgitrac website!
We are thrilled to announce the launch of our brand-new website—crafted with our audience in mind.Triamcinolone (TA) deposits following subcutaneous injection to treat chalazion
Chalazia are chronic lipogranulomatous inflammations of the eyelid secondary to a blocked meibomian gland. Whilst most resolve spontaneously, certain chalazia warrant treatment. Options include incision and curettage (I&C), lesion excision, intralesional steroid injections, and botox injections [1]. I&C is usually...
Postoperative diplopia test with BT for inferior oblique overaction
The authors evaluate a novel assessment of botulinum toxin (BT) injection into the inferior oblique (IO) as a postoperative test in those with secondary IO overaction. This was a retrospective review of 23 injections for 18 patients using 1.25U of...
Extraocular muscle BT after ocular pathology
Management is described for 13 patients who received inferior rectus botulinum toxin (BT) injection for vertical strabismus due to orbital pathology. Patients were aged 19-86 years, eight were female and seven were right eye injections. Orbital pathology included six with...
Cell injection therapy for endothelial failure
This is a prospective observational study involving 11 eyes of 11 patients with pseudophakic endothelial failure who underwent human corneal endothelial cell culture (hCEC) injection therapy for endothelial failure. This study aimed to evaluate the long-term five-year postoperative data for...
BT outcomes under open versus closed sky technique
This retrospective study compared open versus closed sky BT injection techniques without electromyography (EMG) control in 135 patients (31 open sky and 104 closed). Patients were aged 1-50 years for open sky and 2-34 years for closed. There was a...
Outcomes of reinjection of Ranibizumab for reactivation of retinopathy of prematurity
The authors present their data from Egypt assessing the effects of Ranibizumab reinjection for neonates with retinopathy of prematurity (ROP). Doses given were 0.25mg/0.025mL. They screened 2318 infants with 115 (5%) of infants with a mean post menstrual age (PMA)...
Review of bupivacaine use in treatment of strabismus
This review aimed to assess the applications of bupivacaine (B) in the non-surgical treatment of strabismus in human and animal studies. Animal studies show that singly-innervated fibres with low concentrations of mitochondria and developed sarcoplasmic reticulum are more affected by...
BTA injection to treat convergence insufficiency
The outcomes of patients with convergence insufficiency (CI) treatment with botulinum toxin A (BTA) in one or both lateral rectus muscles are reported. This was a retrospective study of 23 patients; eight males, 15 female, mean age 59 years (range...
Comparison of bupivacaine injection vs. mini-tenotomy for small angle deviations
Bupivacaine hydrochloride is an aminoacyltype local anaesthetic. Injection into extraocular muscles elicits a myotoxic response destroying striated muscle fibres but sparing satellite cells, nerves and vessels. Preserved satellite cells proliferate to form new muscle fibres, causing muscle hypertrophy and greater...
BT vs primary surgery for infantile esotropia
In this study, the success rate of treatment for infantile esotropia (IET) patients who had surgery because of under correction after botulinum toxin (BT) is compared to those having primary surgery. The study included 52 patients (27 male) with mean...
